Free Trial

Salvus Wealth Management LLC Cuts Position in Moelis & Company (NYSE:MC)

Moelis & Company logo with Finance background

Salvus Wealth Management LLC decreased its position in Moelis & Company (NYSE:MC - Free Report) by 23.2% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 36,559 shares of the asset manager's stock after selling 11,068 shares during the quarter. Moelis & Company accounts for 1.7% of Salvus Wealth Management LLC's portfolio, making the stock its 16th largest position. Salvus Wealth Management LLC's holdings in Moelis & Company were worth $2,701,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also bought and sold shares of MC. Reston Wealth Management LLC purchased a new stake in Moelis & Company during the third quarter valued at about $26,000. GAMMA Investing LLC boosted its holdings in Moelis & Company by 115.8% during the 3rd quarter. GAMMA Investing LLC now owns 995 shares of the asset manager's stock valued at $68,000 after acquiring an additional 534 shares during the period. Blue Trust Inc. boosted its holdings in Moelis & Company by 193.0% during the 3rd quarter. Blue Trust Inc. now owns 1,081 shares of the asset manager's stock valued at $74,000 after acquiring an additional 712 shares during the period. Whittier Trust Co. of Nevada Inc. bought a new position in Moelis & Company during the 3rd quarter worth approximately $75,000. Finally, Benjamin F. Edwards & Company Inc. increased its stake in Moelis & Company by 75.2% in the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 1,465 shares of the asset manager's stock worth $83,000 after purchasing an additional 629 shares during the period. Hedge funds and other institutional investors own 91.53% of the company's stock.

Moelis & Company Price Performance

Moelis & Company stock traded up $0.68 during mid-day trading on Friday, reaching $77.25. 523,424 shares of the company traded hands, compared to its average volume of 785,984. Moelis & Company has a 52-week low of $46.24 and a 52-week high of $81.60. The firm has a market capitalization of $5.79 billion, a price-to-earnings ratio of 145.76 and a beta of 1.39. The firm's 50 day moving average price is $74.79 and its 200 day moving average price is $69.07.

Moelis & Company (NYSE:MC - Get Free Report) last issued its quarterly earnings data on Wednesday, October 23rd. The asset manager reported $0.22 EPS for the quarter, topping the consensus estimate of $0.20 by $0.02. The business had revenue of $273.76 million during the quarter, compared to analyst estimates of $273.58 million. Moelis & Company had a net margin of 4.22% and a return on equity of 12.15%. Moelis & Company's quarterly revenue was up .6% compared to the same quarter last year. During the same period last year, the business posted ($0.15) earnings per share. On average, sell-side analysts anticipate that Moelis & Company will post 1.02 EPS for the current year.

Moelis & Company Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Monday, December 2nd. Investors of record on Monday, November 4th were given a dividend of $0.60 per share. The ex-dividend date of this dividend was Monday, November 4th. This represents a $2.40 annualized dividend and a dividend yield of 3.11%. Moelis & Company's dividend payout ratio is presently 452.83%.

Analyst Ratings Changes

MC has been the subject of a number of analyst reports. UBS Group increased their price objective on Moelis & Company from $54.00 to $60.00 and gave the company a "sell" rating in a research note on Tuesday, October 8th. Morgan Stanley raised shares of Moelis & Company from an "underweight" rating to an "overweight" rating and increased their price target for the company from $66.00 to $92.00 in a research report on Monday, December 9th. Keefe, Bruyette & Woods raised shares of Moelis & Company from a "market perform" rating to an "outperform" rating and raised their price target for the stock from $71.00 to $86.00 in a report on Friday, December 20th. Finally, Wells Fargo & Company lowered their price objective on shares of Moelis & Company from $78.00 to $77.00 and set an "equal weight" rating for the company in a research note on Tuesday. One analyst has rated the stock with a sell rating, five have given a hold rating and two have issued a buy rating to the company. According to MarketBeat, the company currently has a consensus rating of "Hold" and a consensus target price of $70.67.

Get Our Latest Stock Analysis on Moelis & Company

Moelis & Company Profile

(Free Report)

Moelis & Company operates as an investment banking advisory firm. It offers advisory services in the areas of mergers and acquisitions, recapitalizations and restructurings, capital markets transactions, and other corporate finance matters, as well as strategic, capital structure, and private funds advisory.

Further Reading

Institutional Ownership by Quarter for Moelis & Company (NYSE:MC)

Should You Invest $1,000 in Moelis & Company Right Now?

Before you consider Moelis & Company, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Moelis & Company wasn't on the list.

While Moelis & Company currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2024 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Crypto Boom 2025: Bitcoin’s Rise and Trump’s Impact on the Market
Goldman Sachs’ 2025 Market Outlook: Top 3 Stock Picks
7 Stocks to Benefit From Trump’s Tariffs in 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines